Partnerships between sponsor companies and contract manufacturers can take on endless variations. Louis Garguilo, Chief Editor of Outsourced Pharma explores several successful sponsor-CDMO relationships by talking to the participants involved.
Mauritz Venter, CEO of AzarGen Biotechnologies discusses his company’s relationship with CDMO iBio and its company president, R. Barry Holtz, outlines the “empowerment model” that makes it work. Sponsors are quick to demand more efficiencies and better outcomes from their CDMOs, but ImmunoGen executive, Shawn Eisenberg, explains how looking internally can drive better performance from your external partners. Can small biotechs stand on equal footing with their CDMO partners? Yes, say two executives from biotech Genisphere. They discuss how their company selects and works with larger CDMO partners.